Gene · 574032
Papers2,366
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,366
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Advances in vaginal microbiome and metabolite research: genetics, evolution, and clinical perspectives. | Front Cell Infect Microbiol | 2025 | 41473770 | PubTator, text mining | PubMed |
| M1 macrophage-derived exosomal miR-20b promotes radiosensitization via CCND1 in HPV+ HNSCC. | Front Oncol | 2025 | 41395621 | PubTator, text mining | PubMed |
Exosomal microRNA-20b-5p contributes to cytarabine resistance in acute myeloid leukemia via the microtubule-associated serine/threonine kinase-like-phosphatidylinositol 3-kinase-protein kinase B signaling axis. | Int J Biol Macromol | 2025 | 41197693 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| Navigating the Landscape of Exosomal microRNAs: Charting Their Pivotal Role as Biomarkers in Hematological Malignancies. | Noncoding RNA | 2025 | 40981381 | PubTator, text mining | PubMed |
| Lnc-THAP7-AS1 suppresses the ovarian cancer progression by targeting miR-92b-5p/fatty acid 2-hydroxylase signal axis. | Transl Oncol | 2025 | 40876104 | PubTator, text mining | PubMed |
| Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. | Signal Transduct Target Ther | 2025 | 40841367 | PubTator, text mining | PubMed |
| Childhood resolution of early abnormal miRNA following neonatal encephalopathy. | Sci Rep | 2025 | 40830168 | PubTator, text mining | PubMed |
| Epigenetic modifications of gut microbiota and their potential role in atherosclerosis. | Front Pharmacol | 2025 | 40740992 | PubTator, text mining | PubMed |
| Integrated Analysis of Slow Transit Constipation and Colorectal Cancer Reveals the Co-Pathogenic Targets and Their Potential Clinical Value. | Cancer Invest | 2025 | 40454893 | PubTator, text mining | PubMed |
| Epigenetics of maternal-fetal interface immune microenvironment and placental related pregnancy complications. | Front Immunol | 2025 | 40248704 | PubTator, text mining | PubMed |
| Extracellular vesicles derived microRNAs as non-invasive markers of liver fibrosis in chronically infected HCV patients: a pilot study. | Noncoding RNA Res | 2025 | 40176849 | PubTator, text mining | PubMed |
| The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activation. | Leukemia | 2025 | 40097604 | PubTator, text mining | PubMed |
| Role of furin in the severity of COVID-19 infection via effects on miR-20b and miR-106a. | Mol Biol Rep | 2025 | 40095093 | PubTator, text mining | PubMed |
| The YTHDC1 reader protein recognizes and regulates the lncRNA MEG3 following its METTL3-mediated m6A methylation: a novel mechanism early during radiation-induced liver injury. | Cell Death Dis | 2025 | 39994235 | PubTator, text mining | PubMed |
| High-Throughput Computer Screen Aids Discovery of Methotrexate as miR-20b Inhibitor to Suppress Nonsmall Cell Lung Cancer Progression. | ACS Chem Biol | 2025 | 39736132 | PubTator, text mining | PubMed |
| miR-124, miR-126-3p, and miR-200b: Potential therapeutic targets for VEGF-mediated complications in proliferative diabetic retinopathy. | Indian J Ophthalmol | 2025 | 39728608 | PubTator, text mining | PubMed |
| Analysis of MiR-20b, MIR-197 markers for differentiation between forensic body fluids encountered in sexual assault cases. | Forensic Sci Med Pathol | 2025 | 38856935 | PubTator, text mining | PubMed |
| Circulating microRNAs as a Prognostic Tool to Determine Treatment Efficacy in Lung Cancer Patients Undergoing Pembrolizumab PD-1 Blockade Immunotherapy. | Cancers (Basel) | 2024 | 39766101 | PubTator, text mining | PubMed |
| Abnormal microRNA expression profile at early stages of gestation in pregnancies destined to develop placenta previa. | Front Med (Lausanne) | 2024 | 39691371 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/574032/papers?page=2